Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed, reflecting a page version metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRemoved the government funding lapse notice; the study details content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedNo meaningful content changes detected between the two screenshots; no additions or deletions affecting core content, navigation, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange Detected- Added a government funding/operating status notice and a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the resource: Genetic and Rare Diseases Information Center resources: Carcinoma of esophagus (v3.1.0).SummaryDifference2%

- Check70 days agoChange DetectedUpdated contact details and new software revision (v3.1.0) replace an old disease term and older revision (v3.0.2).SummaryDifference0.2%

- Check85 days agoChange DetectedThe page version updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' navigation element was removed.SummaryDifference0.1%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.